Last reviewed · How we verify
Cyclosporine A, Tacrolimus, Sirolimus
Cyclosporine A, Tacrolimus, Sirolimus is a Small molecule drug developed by Central South University. It is currently FDA-approved.
At a glance
| Generic name | Cyclosporine A, Tacrolimus, Sirolimus |
|---|---|
| Sponsor | Central South University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy (PHASE3)
- A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256) (PHASE2)
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS) (PHASE2)
- Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease (PHASE4)
- CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial (PHASE3)
- New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)
- Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients (PHASE4)
- Microsampling Assays for Immunosuppressive Drugs in Children
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cyclosporine A, Tacrolimus, Sirolimus CI brief — competitive landscape report
- Cyclosporine A, Tacrolimus, Sirolimus updates RSS · CI watch RSS
- Central South University portfolio CI
Frequently asked questions about Cyclosporine A, Tacrolimus, Sirolimus
What is Cyclosporine A, Tacrolimus, Sirolimus?
Cyclosporine A, Tacrolimus, Sirolimus is a Small molecule drug developed by Central South University.
Who makes Cyclosporine A, Tacrolimus, Sirolimus?
Cyclosporine A, Tacrolimus, Sirolimus is developed and marketed by Central South University (see full Central South University pipeline at /company/central-south-university).
What development phase is Cyclosporine A, Tacrolimus, Sirolimus in?
Cyclosporine A, Tacrolimus, Sirolimus is FDA-approved (marketed).